R. U. Yuldashova

R. U. Yuldashova

Auto-generated profile, based on publicly available information

R. U. Yuldashova

Bukhara State Medical Institute, Bukhara, Republic of Uzbekistan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2024 in Cardiovascular Therapy and Prevention
Verified
Journal Article
Open access
PDF file
ODOxana M. Drapkina
Oxana M. Drapkina
AKA. V. Kontsevaya
A. V. Kontsevaya
AKA. M. Kalinina
A. M. Kalinina
SASergey Avdeev
Sergey Avdeev
MAM. V. Agaltsov
M. V. Agaltsov
БДБ. Ю. Джонова
Б. Ю. Джонова
Создание руководства поддержано Советом по терапевтическим наукам отделения клинической медицины Российской академии наук.

11 April 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ABAidos Bolatov
Aidos Bolatov
NBNurlan Brimkulov
Nurlan Brimkulov
GJGaukhar Jarylkasynova
Gaukhar Jarylkasynova
ATAinura Taalaikanova
Ainura Taalaikanova
RYRano Yuldashova
Rano Yuldashova
TSTelman Z. Seisembekov
Telman Z. Seisembekov
Occupational burnout (OB) among healthcare workers (HCWs) has significant implications for workforce sustainability and patient care. The COVID-19 pandemic exacerbated existing stressors, highlighting the urgent need to investigate burnout prevalence and associated factors among HCWs in Central Asia (CA). This study aimed to assess burnout levels, explore contributing factors, and evaluate the impact of job satisfaction and pandemic-related stressors. A cross-sectional online survey was conducted between July and November 2022 among physicians and nurses in Kazakhstan, Kyrgyzstan, and Uzbekistan. The survey included the Copenhagen Burnout Inventory (CBI), a validated job satisfaction scale, and a measure assessing the impact of COVID-19 on work and personal life. Burnout prevalence and associated factors were analyzed using regression modeling and mediation analysis. Among 2685 HCWs (Kazakhstan: 67.7%, Kyrgyzstan: 19.9%, Uzbekistan: 12.4%), the overall prevalence of OB was 28.3%. Physicians had higher burnout levels than nurses, with job satisfaction playing a mediating role in this disparity in Kazakhstan and Kyrgyzstan. A poor work environment and high job demands were strongly linked to OB (p < 0.001). HCWs with severe COVID-19 histories experienced significantly greater burnout (OR 1.346–2.270, p < 0.05). Pandemic-related stressors, including social stigma, excessive workload, and lack of appreciation, were significant predictors of burnout. OB remains a critical issue among HCWs in CA, with job satisfaction, workplace conditions, and pandemic-related stressors playing key roles. Targeted interventions, such as workload optimization, institutional support, and mental health resources, are essential to mitigate OB and improve HCW well-being.

30 June 2026 in Наука и здравоохранение
Verified
Journal Article
Closed access
SKSh.S. Kodirova
Sh.S. Kodirova
GJG.J. Jarylkasynova
G.J. Jarylkasynova
RYR.U. Yuldashova
R.U. Yuldashova
Introduction. The COVID-19 pandemic has led to a significant increase in psychoemotional disorders among patients with cardiovascular diseases. Anxiety-depressive states in this group of patients may worsen the course of the underlying pathology and reduce the effectiveness of ongoing therapy. Aim of the study. To optimize the methods of correction of psychoemotional disorders in patients with cardiovascular diseases who have recovered from COVID-19 based on the analysis of their psychological status, clinical characteristics, and biochemical indicators. Materials and methods. A clinical observational study was conducted involving 259 patients with cardiovascular diseases who had recovered from COVID-19. The psychoemotional status of patients was assessed using the HADS, Hamilton, and Zung scales. Additionally, biochemical markers of inflammation and oxidative stress were analyzed, including C-reactive protein (CRP), interleukin-6, cortisol, homocysteine, and glutathione. Statistical analysis of the data was performed using the SPSS software. Results. Anxiety-depressive disorders of varying severity were identified in the majority of patients. A statistically significant relationship was found between the severity of psychoemotional disorders and the levels of inflammatory and hormonal markers. The use of complex therapy including antidepressants (Rexetin, Mirtazapine) contributed to a decrease in anxiety and depression levels and improved the quality of life of patients. Conclusions. The obtained results indicate the need for a comprehensive approach to the treatment of patients with cardiovascular diseases after COVID-19, taking into account their psychoemotional status. Введение. Пандемия COVID-19 привела к значительному увеличению распространенности психоэмоциональных расстройств среди пациентов с сердечно-сосудистыми заболеваниями. Тревожно-депрессивные состояния у данной категории пациентов могут ухудшать течение основного заболевания и снижать эффективность проводимой терапии. Цель исследования. Оптимизировать методы коррекции психоэмоциональных расстройств у пациентов с сердечно-сосудистыми заболеваниями, перенесших COVID-19, на основе анализа их психоэмоционального состояния, клинических характеристик и биохимических показателей. Материалы и методы. Проведено клиническое наблюдательное исследование с участием 259 пациентов с сердечно-сосудистыми заболеваниями, перенесших COVID-19. Психоэмоциональное состояние пациентов оценивали с использованием шкал HADS, Гамильтона и Зунга. Кроме того, исследовали биохимические маркеры воспаления и окислительного стресса, включая С-реактивный белок (СРБ), интерлейкин-6, кортизол, гомоцистеин и глутатион. Статистическую обработку данных выполняли с использованием программного обеспечения SPSS. Результаты. У большинства пациентов были выявлены тревожно-депрессивные расстройства различной степени выраженности. Установлена статистически значимая взаимосвязь между выраженностью психоэмоциональных расстройств и уровнями воспалительных и гормональных маркеров. Применение комплексной терапии, включавшей антидепрессанты (Рексетин, миртазапин), способствовало снижению уровня тревоги и депрессии, а также улучшению качества жизни пациентов. Выводы. Полученные результаты свидетельствуют о необходимости комплексного подхода к лечению пациентов с сердечно-сосудистыми заболеваниями, перенесших COVID-19, с обязательным учетом их психоэмоционального статуса. Кіріспе. COVID-19 пандемиясы жүрек-қантамыр аурулары бар пациенттер арасында психоэмоционалдық бұзылыстардың таралуының едәуір артуына әкелді. Пациенттердің осы санатындағы үрей мен депрессия негізгі аурудың ағымын нашарлатып, жүргізілетін емнің тиімділігін төмендетуі мүмкін. Зерттеудің мақсаты. Психоэмоционалдық жағдайды, клиникалық сипаттамаларды және биохимиялық көрсеткіштерді талдау негізінде COVID-19 инфекциясын бастан өткерген жүрек-қантамыр аурулары бар пациенттердегі психоэмоционалдық бұзылыстарды түзету әдістерін оңтайландыру. Материалдар мен әдістер....